Nose to brain delivery of ibudilast micelles for treatment of multiple sclerosis in an experimental autoimmune encephalomyelitis animal model
-
Published:2023-05
Issue:
Volume:638
Page:122936
-
ISSN:0378-5173
-
Container-title:International Journal of Pharmaceutics
-
language:en
-
Short-container-title:International Journal of Pharmaceutics
Author:
Sharifian Akram,
Varshosaz JalehORCID,
Aliomrani MehdiORCID,
Kazemi MohammadORCID
Subject
Pharmaceutical Science
Reference73 articles.
1. Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis;Akaishi;J. Neuroimmunol.,2018
2. White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments;Akaishi;Sci. Rep.,2021
3. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?;Barkhof;Neurology,2010
4. Abnormal B-cell cytokine responses a trigger of T-cell–mediated disease in MS?;Bar-Or;Ann. Neurol.,2010
5. Bernsmann, F., Ball, V., Addiego, F., Ponche, A., Michel, M., Gracio, J.J. de A., Toniazzo, V., Ruch, D., 2011. Dopamine− melanin film deposition depends on the used oxidant and buffer solution. Langmuir 27, 2819–2825.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献